bibliographic resource 8212791 [br/8212791]
https://w3id.org/oc/corpus/br/8212791

is a

• document
• article

title

• 1033PSUBGROUP ANALYSES OF A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF LENVATINIB (E7080) IN PATIENTS WITH 131I-REFRACTORY DIFFERENTIATED THYROID CANCER

publication date

• 2014-01-01

contributor

• https://w3id.org/oc/corpus/ar/31767077
• https://w3id.org/oc/corpus/ar/31767078
• https://w3id.org/oc/corpus/ar/31767079
• https://w3id.org/oc/corpus/ar/31767080
• https://w3id.org/oc/corpus/ar/31767081
• https://w3id.org/oc/corpus/ar/31767082
• https://w3id.org/oc/corpus/ar/31767083
• https://w3id.org/oc/corpus/ar/31767084
• https://w3id.org/oc/corpus/ar/31767085
• https://w3id.org/oc/corpus/ar/31767086
• https://w3id.org/oc/corpus/ar/31767087
• https://w3id.org/oc/corpus/ar/31767088
• https://w3id.org/oc/corpus/ar/31767089
• https://w3id.org/oc/corpus/ar/31767090
• https://w3id.org/oc/corpus/ar/31767091
• https://w3id.org/oc/corpus/ar/31767092
• https://w3id.org/oc/corpus/ar/31767093
• https://w3id.org/oc/corpus/ar/31767094
• https://w3id.org/oc/corpus/ar/31767095
• https://w3id.org/oc/corpus/ar/31767096

format

• https://w3id.org/oc/corpus/re/4788256

identifier

• https://w3id.org/oc/corpus/id/16860382
• https://w3id.org/oc/corpus/id/16860383

part of

• https://w3id.org/oc/corpus/br/3936477